$NEOG
NEOGEN CORP

2014 Q1 Form 10-Q Financial Statement

#000119312514131692 Filed on April 04, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q2 2013 Q1
Revenue $62.00M $56.01M $51.06M
YoY Change 21.43% 15.37% 13.68%
Cost Of Revenue $31.29M $27.60M $23.74M
YoY Change 31.8% 12.2% 7.82%
Gross Profit $30.71M $28.38M $27.31M
YoY Change 12.42% 18.75% 19.31%
Gross Profit Margin 49.53% 50.67% 53.5%
Selling, General & Admin $18.31M $16.30M $15.67M
YoY Change 16.86% 20.74% 15.28%
% of Gross Profit 59.62% 57.43% 57.35%
Research & Development $2.106M $1.900M $1.982M
YoY Change 6.26% 11.76% 13.0%
% of Gross Profit 6.86% 6.69% 7.26%
Depreciation & Amortization $2.470M $2.140M $1.980M
YoY Change 24.75% 27.38% 25.32%
% of Gross Profit 8.04% 7.54% 7.25%
Operating Expenses $20.41M $18.20M $17.65M
YoY Change 15.67% 19.74% 15.02%
Operating Profit $10.29M $10.18M $9.666M
YoY Change 6.49% 17.04% 28.04%
Interest Expense $0.00 $0.00 $0.00
YoY Change
% of Operating Profit 0.0% 0.0% 0.0%
Other Income/Expense, Net -$40.00K -$100.0K $394.0K
YoY Change -110.15% -66.67% -31.0%
Pretax Income $10.25M $10.10M $10.06M
YoY Change 1.92% 20.24% 23.89%
Income Tax $3.700M $3.200M $3.450M
% Of Pretax Income 36.09% 31.68% 34.29%
Net Earnings $6.575M $7.031M $6.652M
YoY Change -1.16% 16.64% 26.85%
Net Earnings / Revenue 10.61% 12.55% 13.03%
Basic Earnings Per Share $0.18 $0.19 $0.19
Diluted Earnings Per Share $0.18 $0.19 $0.19
COMMON SHARES
Basic Shares Outstanding 36.61M shares 24.07M shares 35.84M shares
Diluted Shares Outstanding 37.23M shares 36.60M shares

Balance Sheet

Concept 2014 Q1 2013 Q2 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $68.80M $85.40M $74.60M
YoY Change -7.77% 24.49% 21.7%
Cash & Equivalents $43.28M $50.03M $48.86M
Short-Term Investments $25.50M $35.30M $25.70M
Other Short-Term Assets $7.300M $6.100M $5.700M
YoY Change 28.07% 32.61% 35.71%
Inventory $51.86M $38.32M $41.08M
Prepaid Expenses
Receivables $48.07M $38.74M $38.69M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $176.0M $168.4M $160.1M
YoY Change 9.93% 17.03% 17.53%
LONG-TERM ASSETS
Property, Plant & Equipment $39.84M $34.35M $33.41M
YoY Change 19.23% 14.74% 13.27%
Goodwill $70.73M $59.49M $61.73M
YoY Change 14.58% 12.14%
Intangibles $23.61M $12.35M
YoY Change 14.03%
Long-Term Investments
YoY Change
Other Assets $114.5M $87.77M $87.54M
YoY Change 30.85% 12.92%
Total Long-Term Assets $154.4M $122.1M $121.0M
YoY Change 27.64% 13.42% 16.14%
TOTAL ASSETS
Total Short-Term Assets $176.0M $168.4M $160.1M
Total Long-Term Assets $154.4M $122.1M $121.0M
Total Assets $330.4M $290.6M $281.0M
YoY Change 17.55% 15.48% 16.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.77M $9.212M $9.948M
YoY Change 18.34% -14.39% 29.19%
Accrued Expenses $11.20M $8.300M $8.800M
YoY Change 27.27% -1.19% 23.94%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $24.53M $17.72M $22.57M
YoY Change 8.71% -11.31% 29.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.200M $2.100M $2.000M
YoY Change 10.0% -19.23% -56.52%
Total Long-Term Liabilities $14.69M $14.55M $12.76M
YoY Change 15.16% 15.8% 177.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.53M $17.72M $22.57M
Total Long-Term Liabilities $14.69M $14.55M $12.76M
Total Liabilities $39.23M $32.27M $35.33M
YoY Change 11.04% -0.84% 15.07%
SHAREHOLDERS EQUITY
Retained Earnings $174.5M $153.9M $146.9M
YoY Change 18.83% 21.46%
Common Stock $5.862M $5.773M $3.827M
YoY Change 53.17% 52.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $291.2M $258.2M $245.6M
YoY Change
Total Liabilities & Shareholders Equity $330.4M $290.6M $281.0M
YoY Change 17.55% 15.48% 16.95%

Cashflow Statement

Concept 2014 Q1 2013 Q2 2013 Q1
OPERATING ACTIVITIES
Net Income $6.575M $7.031M $6.652M
YoY Change -1.16% 16.64% 26.85%
Depreciation, Depletion And Amortization $2.470M $2.140M $1.980M
YoY Change 24.75% 27.38% 25.32%
Cash From Operating Activities $6.430M $6.670M $8.560M
YoY Change -24.88% -26.22% 21.07%
INVESTING ACTIVITIES
Capital Expenditures -$2.860M -$1.930M -$3.600M
YoY Change -20.56% 21.38% 87.5%
Acquisitions
YoY Change
Other Investing Activities -$7.240M -$9.640M $430.0K
YoY Change -1783.72% 131.73%
Cash From Investing Activities -$10.10M -$11.56M -$3.170M
YoY Change 218.61% 100.69% 65.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.140M 6.100M 2.390M
YoY Change 31.38% 92.43% 246.38%
NET CHANGE
Cash From Operating Activities 6.430M 6.670M 8.560M
Cash From Investing Activities -10.10M -11.56M -3.170M
Cash From Financing Activities 3.140M 6.100M 2.390M
Net Change In Cash -530.0K 1.210M 7.780M
YoY Change -106.81% -81.24% 33.22%
FREE CASH FLOW
Cash From Operating Activities $6.430M $6.670M $8.560M
Capital Expenditures -$2.860M -$1.930M -$3.600M
Free Cash Flow $9.290M $8.600M $12.16M
YoY Change -23.6% -19.1% 35.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2008Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
1125000 shares
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36666898 shares
CY2013Q1 us-gaap Assets
Assets
281025000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48861000
CY2014Q1 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0117 pure
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36643516 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
25.15
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1966000 shares
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.16
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36643516 shares
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
24534000
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
336000
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3166000
CY2014Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
291124000
CY2014Q1 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
916000
CY2014Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8063000
CY2014Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
110497000
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
11772000
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
291201000
CY2014Q1 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
2243000
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
174506000
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1150000
CY2014Q1 us-gaap Minority Interest
MinorityInterest
-77000
CY2014Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
12000000
CY2014Q1 us-gaap Liabilities
Liabilities
39226000
CY2014Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
14692000
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
5862000
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
330350000
CY2014Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
12449000
CY2014Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1533000
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
114543000
CY2014Q1 us-gaap Goodwill
Goodwill
70728000
CY2014Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23610000
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
48068000
CY2014Q1 us-gaap Inventory Net
InventoryNet
51861000
CY2014Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
25601000
CY2014Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1462000
CY2014Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
22258000
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39838000
CY2014Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
12270000
CY2014Q1 us-gaap Assets
Assets
330350000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43277000
CY2014Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4002000
CY2014Q1 us-gaap Other Indefinite Lived Intangible Assets
OtherIndefiniteLivedIntangibleAssets
7935000
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5768000
CY2014Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
25533000
CY2014Q1 us-gaap Assets Current
AssetsCurrent
175969000
CY2014Q1 neog Accumulated Amortization Of Acquired Intangible Assets
AccumulatedAmortizationOfAcquiredIntangibleAssets
10629000
CY2014Q1 neog Other Intangible Assets Accumulated Amortization
OtherIntangibleAssetsAccumulatedAmortization
5800000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49045000
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36084021 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.21
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2091000 shares
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.16
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36084021 shares
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
17719000
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1372000
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3227000
CY2013Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
258287000
CY2013Q2 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
916000
CY2013Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5115000
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
99935000
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
9212000
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
258221000
CY2013Q2 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
2103000
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
153885000
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
900000
CY2013Q2 us-gaap Minority Interest
MinorityInterest
66000
CY2013Q2 us-gaap Liabilities
Liabilities
32271000
CY2013Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
14552000
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
5773000
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
290558000
CY2013Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
12449000
CY2013Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
165000
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
87766000
CY2013Q2 us-gaap Goodwill
Goodwill
59491000
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12345000
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
38737000
CY2013Q2 us-gaap Inventory Net
InventoryNet
38315000
CY2013Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
18145000
CY2013Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1462000
CY2013Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
16587000
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34345000
CY2013Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
9270000
CY2013Q2 us-gaap Assets
Assets
290558000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50032000
CY2013Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3583000
CY2013Q2 us-gaap Other Indefinite Lived Intangible Assets
OtherIndefiniteLivedIntangibleAssets
6660000
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4564000
CY2013Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
35337000
CY2013Q2 us-gaap Assets Current
AssetsCurrent
168447000
CY2013Q2 neog Accumulated Amortization Of Acquired Intangible Assets
AccumulatedAmortizationOfAcquiredIntangibleAssets
9446000
CY2013Q2 neog Other Intangible Assets Accumulated Amortization
OtherIntangibleAssetsAccumulatedAmortization
4222000
CY2013Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1.5 pure
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36455000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
756000 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19888000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35699000 shares
us-gaap Sales Revenue Net
SalesRevenueNet
151522000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-71000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4612000
us-gaap Cost Of Revenue
CostOfRevenue
70409000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5272000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1868000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
6971000
us-gaap Investment Income Interest
InvestmentIncomeInterest
114000
us-gaap Profit Loss
ProfitLoss
20064000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
19898000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
56160000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
135429000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
13318000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
522000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1868000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
16093000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
31014000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-166000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2607000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1301000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
19992000
us-gaap Gross Profit
GrossProfit
81113000
us-gaap Operating Income Loss
OperatingIncomeLoss
30470000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-92000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
544000
us-gaap Net Income Loss
NetIncomeLoss
20158000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4851000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
61063000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-94000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14510000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6393000
us-gaap Cost Of Services
CostOfServices
9346000
us-gaap Share Based Compensation
ShareBasedCompensation
2198000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-184000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
30232000
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
-87000
us-gaap Operating Expenses
OperatingExpenses
50643000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10950000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2198000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
50055000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26394000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5901000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-94000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2981000
dei Trading Symbol
TradingSymbol
NEOG
dei Entity Registrant Name
EntityRegistrantName
NEOGEN CORP
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
36.44
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2014-09-01
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2014-02-28
dei Entity Central Index Key
EntityCentralIndexKey
0000711377
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
21.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
512000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.008 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37149000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
678000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.331 pure
us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
LIBOR plus 100 basis points
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.87
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0100 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17162000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
556000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
81000 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
112026 shares
us-gaap Operating Income Loss
OperatingIncomeLoss
32400000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6789000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10035000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
963000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22329000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
159198000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
39265000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-610000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
3948000
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
20945000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
31878000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1708000
us-gaap Gross Profit
GrossProfit
90560000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
13.74
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36471000 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segment
us-gaap Sales Revenue Net
SalesRevenueNet
180143000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
7347000
us-gaap Investment Income Interest
InvestmentIncomeInterest
88000
us-gaap Profit Loss
ProfitLoss
20478000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
22186000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
67192000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
0
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-522000
us-gaap Net Income Loss
NetIncomeLoss
20621000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4060000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
616000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
76234000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-143000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18135000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12228000
us-gaap Cost Of Services
CostOfServices
13349000
us-gaap Share Based Compensation
ShareBasedCompensation
2689000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
923000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6756000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
33529000
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
168000
us-gaap Operating Expenses
OperatingExpenses
58160000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11400000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
662000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8112000
us-gaap Cost Of Revenue
CostOfRevenue
89583000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6641000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3948000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2689000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
76996000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36808000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6496000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-143000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3114000
neog Accrual For Environmental Loss Contingencies Undiscounted Estimated Period
AccrualForEnvironmentalLossContingenciesUndiscountedEstimatedPeriod
P15Y
neog Environmental Remediation Expense Period Of Remediation
EnvironmentalRemediationExpensePeriodOfRemediation
P5Y
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.012 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.392 pure
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.20
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36603000 shares
CY2013Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
762000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35841000 shares
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
51055000
CY2013Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
33000
CY2013Q1 us-gaap Profit Loss
ProfitLoss
6610000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5966000
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
44124000
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-40000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
6575000
CY2014Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
26933000
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-68000
CY2014Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
7373000
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
10253000
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
497000
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7072000
CY2014Q1 us-gaap Gross Profit
GrossProfit
30705000
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
10293000
CY2014Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
0
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
401000
CY2013Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
6931000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
10060000
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-644000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6008000
CY2013Q1 us-gaap Gross Profit
GrossProfit
27313000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
9666000
CY2013Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
-40000
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
394000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
6652000
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
20049000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-42000
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5132000
CY2013Q1 us-gaap Cost Of Services
CostOfServices
3693000
CY2013Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10533000
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
17647000
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3450000
CY2013Q1 us-gaap Cost Of Revenue
CostOfRevenue
23742000
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
791000
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1982000
CY2013Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-42000
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37233000 shares
CY2014Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
620000 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36613000 shares
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
61996000
CY2014Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
28000
CY2014Q1 us-gaap Profit Loss
ProfitLoss
6553000
CY2014Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
7050000
CY2014Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
54623000
CY2014Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-22000
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6320000
CY2014Q1 us-gaap Cost Of Services
CostOfServices
4358000
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11986000
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
20412000
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3700000
CY2014Q1 us-gaap Cost Of Revenue
CostOfRevenue
31291000
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
993000
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2106000
CY2014Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-22000

Files In Submission

Name View Source Status
0001193125-14-131692-index-headers.html Edgar Link pending
0001193125-14-131692-index.html Edgar Link pending
0001193125-14-131692.txt Edgar Link pending
0001193125-14-131692-xbrl.zip Edgar Link pending
d688515d10q.htm Edgar Link pending
d688515dex311.htm Edgar Link pending
d688515dex312.htm Edgar Link pending
d688515dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
neog-20140228.xml Edgar Link completed
neog-20140228.xsd Edgar Link pending
neog-20140228_cal.xml Edgar Link unprocessable
neog-20140228_def.xml Edgar Link unprocessable
neog-20140228_lab.xml Edgar Link unprocessable
neog-20140228_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending